tablets "Tigofast-180" are applied to symptomatic treatment of a chronic idiopathic small tortoiseshell at adults and children is more senior than 12 years.

Structure

Active ingredient - a feksofenadina a hydrochloride (one tablet, coated, supports a feksofenadin of a hydrochloride of 180 mg).

Excipients: microcrystalline cellulose, starch corn, sodium krakhmalglikolit (type A), silicon dioxide colloidal anhydrous, a film covering of Insta Coat Sunset Yellow (ethyl cellulose, a hydroksipropilmetiltsellyuloza, "A yellow decline of FCF" (E 110)), talc.

Contraindication

• hypersensitivity to medicament components;
• age up to 12 years.

Route of administration

to Adults and children is more senior than 12 years to appoint medicament in chronic idiopathic urticaria - 180 mg of 1 times a day. To accept inside before food, washing down with water. Duration of treatment is determined individually, depending on disease severity.

Feature of use

Pregnant

a hydrochloride cannot be applied during pregnancy, except emergency cases when the expected advantage for mother exceeds possible risk for a fruit.

As feksofenadin gets into breast milk, medicament cannot be used during feeding by a breast.

Children

In this dosage not to use medicament to children up to 12 years.

Drivers

On the basis of a pharmakodinamichesky profile and the known side effects can draw a conclusion that intake of this medicament does not affect ability to run vehicles and to perform the works demanding concentration of attention. When carrying out objective researches it was revealed that medicament has no considerable impact on functions of the central nervous system (CNS). However it is recommended to estimate individual reaction to medicament before beginning control of vehicles or to perform the works demanding concentration of attention.

Majority of messages about overdose of a feksofenadin of a hydrochloride are insufficiently informative

. So, dizziness, drowsiness and dryness in a mouth was registered.

in case of overdose should take usual measures for removal of not absorbed active ingredients. Symptomatic and maintenance therapy is recommended. Removal of a feksofenadin of a hydrochloride from blood by means of a hemodialysis is inefficient.

Side effects

from nervous system: headache, drowsiness, dizziness.

from digestive tract: nausea, diarrhea, spasms in epigastriums.

General disturbances and reactions in the injection site: feeling of increased fatigue.

from the immune system: hypersensitivity reactions, including a Quincke's edema, feeling of compression in a breast, an asthma, face reddening and system anaphylactic reactions, dispnoe, inflows.

from mentality: insomnia, acrimony and sleep disorders or unusual dreams (paroniriya).

from heart: tachycardia, the strengthened heartbeat.

from skin and hypodermic cellulose: rash, dieback, urticaria, itching.

Medicine contains Yellow Decline of FCF dye (E 110) that can cause allergic reactions.

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

Expiration date - 2 years.